State Street Corp Mirati Therapeutics, Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $17.7 Million - $26.3 Million	-421,700 Reduced 15.36%	2,324,268 $137 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $4.57 Million - $7.45 Million	164,229 Added 6.36%	2,745,968 $120 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $9.82 Million - $13.5 Million	271,919 Added 11.77%	2,581,739 $93.3 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $8.61 Million - $12.8 Million	-235,756 Reduced 9.26%	2,309,820 $85.9 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $40.2 Million - $96.1 Million	974,037 Added 61.98%	2,545,576 $115 Million
Q3 2022 Nov 15, 2022	SELL	$59.5 - $86.7 $18.2 Million - $26.5 Million	-305,076 Reduced 16.26%	1,571,539 $110 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $17.7 Million - $40.2 Million	453,050 Added 31.83%	1,876,615 $126 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $29.4 Million - $58.6 Million	388,101 Added 37.48%	1,423,565 $117 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $15.8 Million - $22.8 Million	119,851 Added 13.09%	1,035,464 $152 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $10 Million - $13.5 Million	75,935 Added 9.04%	915,613 $162 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $31.5 Million - $39.3 Million	-218,493 Reduced 20.65%	839,678 $136 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $2.84 Million - $3.96 Million	-17,862 Reduced 1.66%	1,058,171 $181 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $1.91 Million - $2.84 Million	-11,807 Reduced 1.09%	1,076,033 $236 Million
Q3 2020 Nov 10, 2020	SELL	$113.26 - $167.27 $16.8 Million - $24.8 Million	-148,358 Reduced 12.0%	1,087,840 $181 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $2.56 Million - $4.29 Million	-35,598 Reduced 2.8%	1,236,198 $141 Million
Q1 2020 May 11, 2020	BUY	$69.78 - $116.21 $88.7 Million - $148 Million	1,271,796 New	1,271,796 $97.8 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account